Effect of phosphoinositide-dependent kinase 1 on protein kinase B translocation and its subsequent activation
- PMID: 10891507
- PMCID: PMC86048
- DOI: 10.1128/MCB.20.15.5712-5721.2000
Effect of phosphoinositide-dependent kinase 1 on protein kinase B translocation and its subsequent activation
Abstract
In this report we investigated the function of phosphoinositide-dependent protein kinase 1 (PDK1) in protein kinase B (PKB) activation and translocation to the cell surface. Wild-type and PDK1 mutants were transfected into HeLa cells, and their subcellular localization was analyzed. PDK1 was found to translocate to the plasma membrane in response to insulin, and this process did not require a functional catalytic activity, since a catalytically inactive kinase mutant (Kd) of PDK1 was capable of translocating. The PDK1 presence at the cell surface was shown to be linked to phospholipids and therefore to serum-dependent phosphatidylinositol 3-kinase activity. Using confocal microscopy in HeLa cells we found that PDK1 colocalizes with PKB at the plasma membrane. Further, after cotransfection of PKB and a PDK1 mutant (Mut) unable to translocate to the plasma membrane, PKB was prevented from moving to the cell periphery after insulin stimulation. In response to insulin, a PKB mutant with its PH domain deleted (DeltaPH-PKB) retained the ability to translocate to the plasma membrane when coexpressed with PDK1. Finally, we found that DeltaPH-PKB was highly active independent of insulin stimulation when cotransfected with PDK1 mutants defective in their PH domain. These findings suggest that PDK1 brings PKB to the plasma membrane upon exposure of cells to insulin and that the PH domain of PDK1 acts as a negative regulator of its enzyme activity.
Figures
![FIG. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/86048/bin/mb1501257001.gif)
![FIG. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/86048/bin/mb1501257002.gif)
![FIG. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/86048/bin/mb1501257003.gif)
![FIG. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/86048/bin/mb1501257004.gif)
![FIG. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/86048/bin/mb1501257005.gif)
![FIG. 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/86048/bin/mb1501257006.gif)
![FIG. 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/86048/bin/mb1501257007.gif)
Similar articles
-
Mechanism of phosphorylation of protein kinase B/Akt by a constitutively active 3-phosphoinositide-dependent protein kinase-1.J Biol Chem. 2000 Dec 22;275(51):40400-6. doi: 10.1074/jbc.M003937200. J Biol Chem. 2000. PMID: 11006271
-
3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase.Curr Biol. 1997 Oct 1;7(10):776-89. doi: 10.1016/s0960-9822(06)00336-8. Curr Biol. 1997. PMID: 9368760
-
Role of PDK1 in insulin-signaling pathway for glucose metabolism in 3T3-L1 adipocytes.Am J Physiol Endocrinol Metab. 2002 Jun;282(6):E1385-94. doi: 10.1152/ajpendo.00486.2001. Am J Physiol Endocrinol Metab. 2002. PMID: 12006370
-
PDK1 and PKB/Akt: ideal targets for development of new strategies to structure-based drug design.IUBMB Life. 2003 Mar;55(3):117-26. doi: 10.1080/1521654031000115951. IUBMB Life. 2003. PMID: 12822887 Review.
-
The PI3K-PDK1 connection: more than just a road to PKB.Biochem J. 2000 Mar 15;346 Pt 3(Pt 3):561-76. Biochem J. 2000. PMID: 10698680 Free PMC article. Review.
Cited by
-
Class I PI3K Biology.Curr Top Microbiol Immunol. 2022;436:3-49. doi: 10.1007/978-3-031-06566-8_1. Curr Top Microbiol Immunol. 2022. PMID: 36243838
-
Activation of the essential kinase PDK1 by phosphoinositide-driven trans-autophosphorylation.Nat Commun. 2022 Apr 6;13(1):1874. doi: 10.1038/s41467-022-29368-4. Nat Commun. 2022. PMID: 35387990 Free PMC article.
-
A Complex Interplay of Anionic Phospholipid Binding Regulates 3'-Phosphoinositide-Dependent-Kinase-1 Homodimer Activation.Sci Rep. 2019 Oct 10;9(1):14527. doi: 10.1038/s41598-019-50742-8. Sci Rep. 2019. PMID: 31601855 Free PMC article.
-
Roles of TRAF6 in Central Nervous System.Curr Neuropharmacol. 2018;16(9):1306-1313. doi: 10.2174/1570159X16666180412094655. Curr Neuropharmacol. 2018. PMID: 29651950 Free PMC article. Review.
-
Duvelisib: a phosphoinositide-3 kinase δ/γ inhibitor for chronic lymphocytic leukemia.Expert Opin Investig Drugs. 2017 May;26(5):625-632. doi: 10.1080/13543784.2017.1312338. Epub 2017 Apr 13. Expert Opin Investig Drugs. 2017. PMID: 28388280 Free PMC article. Review.
References
-
- Alessi D, Cohen P. Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev. 1998;8:55–62. - PubMed
-
- Alessi D, Kozlowski M T, Weng Q-P, Morrice N, Avruch J. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr Biol. 1997;8:69–81. - PubMed
-
- Alessi D R, Deak M, Casamayor A, Caudwell F B, Morrice N, Norman D G, Gaffney P, Reese C B, MacDougall C N, Harbison D, Ashworth A, Bownes M. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr Biol. 1997;7:776–789. - PubMed
-
- Alessi D R, James S R, Downes C P, Holmes A B, Gaffney P R J, Reese C B, Cohen P. Characterization of a 3-phosphoinositide-dependent kinase which phosphorylates and activates protein kinase Bα. Curr Biol. 1997;7:261–269. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous